Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma

Similar Items

• Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: Implications for targeted EZH2 inhibitor therapy?
  od: Dubois, Sydney, i dr.
  Izdano: (2015)
• Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis
  od: Bohers, Elodie, i dr.
  Izdano: (2015)
• Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma
  od: Camus, Vincent, i dr.
  Izdano: (2016)
• Prolonged third complete remission after busulfan, thiotepa, and autologous stem cell transplant in a primary central nervous system lymphoma patient
  od: Camus, Vincent, i dr.
  Izdano: (2018)
• Correlations between baseline (18)F-FDG PET tumour parameters and circulating DNA in diffuse large B cell lymphoma and Hodgkin lymphoma
  od: Decazes, Pierre, i dr.
  Izdano: (2020)